Could APOE Gene Therapy Cut Alzheimer's Risk for Millions?

A Nature study shows that variants of the APOE gene largely determine Alzheimer's risk, with APOE3/4 raising risk and APOE2 offering strong protection. Companies are pursuing APOE-targeted gene therapies that could help millions, but brain delivery, regulatory hurdles, and proving cognitive benefit remain major challenges; no proven therapy exists yet.